-
Intranasal Corticosteroids Market to Sustain USD 11.57 Billion by 2034, Driven by Rising Allergic Rhinitis Cases
20 Nov 2025 14:00 GMT
… Pharmaceutical Industries Ltd., Viatris/Mylan, Cipla Limited, Novartis AG, Boehringer … expansion of INCS applications beyond allergic rhinitis. Intranasal Corticosteroids Market Key … Industries Ltd.
Viatris/Mylan
Cipla Limited
Novartis AG
Boehringer …
-
Bayer v. Mylan: “Clinically Proven Effective” Claim Language Fails to Breathe Patentability into Method Claims
08 Oct 2025 01:04 GMT
… Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., No. … artery disease (PAD).2 Mylan and Teva (collectively, Appellees … dosages administered.12 In Allergan the claims provided “ … 1Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., No. 23 …
-
Take allergies seriously!
18 Sep 2025 13:47 GMT
… one food allergy, according to the Food Allergy and Anaphylaxis … prevented.
Under the Food Allergen Labeling and Consumer Protection Act … out of pockecosts for lifesaving allergen medication can be expensive.
… 2022, Epi-Pen’s owner, Mylan, had to cough up $ …
-
Anaphylaxis Treatment Market to Reach $11.6 Billion by 2033 | Driven by Allergies, Auto-Injectors & R&D
28 Aug 2025 13:16 GMT
… the high prevalence of food allergies, advanced healthcare infrastructure, strong … treatment market include:
• Viatris Inc. (Mylan N.V.)
• Pfizer Inc.
• Amneal … announced investments in expanding its allergy immunotherapy pipeline, aiming to …
-
Epinephrine nasal spray yields responses with, without allergic rhinitis
15 Apr 2025 22:27 GMT
… when they also had allergic rhinitis.
Treatment was considered … to simplify protecting severe allergy patients from the potential … 12 participants with seasonal allergic rhinitis who received two … delivered via autoinjector (EpiPen, Mylan), both with and without …
-
Attorney General James Secures up to $335 Million from Pharmaceutical Company Mylan for Its Role in Fueling Opioid Crisis
07 Apr 2025 14:25 GMT
… principle with pharmaceutical company Mylan Inc. (Mylan) that will deliver up … ,” said Attorney General James. “Mylan deceptively marketed its opioid products … Pharmaceuticals, Johnson & Johnson, Mallinckrodt, Allergan, Endo, McKesson, Cardinal Health, …
-
Oncology Biosimilars Market Projected To Witness Substantial Growth, 2025-2032: Amgen Inc., Allergan, Plc, Mylan N.V
27 Feb 2025 11:20 GMT
… Landscape Analysis:
Amgen Inc., Allergan, Plc, Mylan N.V., Samsung Bioepis Co …
-
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
19 Feb 2025 02:31 GMT
… Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. … the claimed invention, citing Allergan USA, Inc. v. … Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir … Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir …
-
Sublingual Allergy Immunotherapy Market Expected to Achieve a Strong 14.24% CAGR, to Reach USD 3.5 Billion by 2032
31 Jan 2025 10:16 GMT
… Pfizer
Allergan
AstraZeneca
Johnson Johnson
Novartis
Teva Pharmaceutical
Merck
Valeant
Mylan
… Dander
Mold
Food
Sublingual Allergy Immunotherapy MarketIndicationOutlook
Allergic Rhinitis
Conjunctivitis
Asthma
…
-
‘Profits over patients’: Indiana Attorney General Todd Rokita files lawsuit against Mylan, Pfizer for EpiPen price spikes
17 Jan 2025 00:00 GMT
… filed a lawsuit alleging that Mylan and Pfizer have conspired to … into patients to combat severe allergic reactions.
“Pharmaceutical companies have prioritized …